16/07/2013

Queen's Joins £10m Biology Centre

Queen’s University in Belfast is to be part of a £10m UK-wide centre to boost links between academia and industry in the field of synthetic biology. Synthetic biology involves the manufacturing of tiny devices from cells and has such uses as producing more sustainable fuels and improving public health.

Queen’s is one of 18 universities and 13 industrial partners that will be involved in the SynbiCITE Innovation and Knowledge Centre, led by Imperial College London.

Professor Christine Maggs, Head of the School of Biological Sciences, will lead Queen’s involvement in SynbiCITE.

Professor Maggs said: "Synthetic biology could be the next 'industrial revolution' for the UK. With potentially huge benefits for health, agriculture, food production, the environment and the production of chemicals, its applications are limitless.

"At Queen’s, we undertake cutting-edge research in biocatalysis, which is a core element of synthetic biology. Biocatalysis involves using natural substances – enzymes or cells – to speed up chemical reactions. Enzymes are at the centre of every reaction that take place in every living thing. They are also used in chemical processes - to produce food, for example, or in tests to diagnose illnesses.

"Our work focusses on creating new methods to develop enzymes in a laboratory setting, so that they can be used in industrial applications. As a SynbiCITE partner, we have the opportunity to collaborate with other leading researchers in this area to help drive forward this important work."

Professor Chris Hardacre, Head of the School of Chemistry and Chemical Engineering, said: "Queen’s involvement in this project will allow the University to take the science of synthetic biology out of academia and into practice. This will provide opportunities for local companies, many of which are already collaborating with us, to access the expertise within the SynbiCITE centre.

"As a member of the EPSRC funded UK Catalysis Hub, for example, we are already conducting ground-breaking research to understand the principles that underpin clean energy production, clean chemical production or 'green chemistry', and environmental protection. This is an area in which we have developed close links with industry in Northern Ireland and beyond, which will continue to flourish as a result of our involvement in SynbiCITE."

(IT/CD)

Related Northern Ireland News Stories
Click here for the latest headlines.

11 August 2015
Queen's Awarded £3.6m From Cancer Research UK
Cancer Research UK has awarded £3.6m to Queen's University, aimed at developing a national digital pathology programme to assist and accelerate the delivery of Precision Medicine in the UK.
06 April 2005
Cancer experts gather at Queen's
Over 150 cancer experts from around the world are meeting at Queen's University this week to discuss the latest developments in cutting-edge research into the disease.
11 November 2003
Boost for biodiversity and conservation biology research
Researchers in the fields of biodiversity and conservation biology were given a boost last night after a new centre was officially opened at Queen’s University Belfast (QUB).
05 September 2013
Almac And QUB In Cancer Research Partnership
A multi-million pound partnership into cancer treatment is to be carried out in Belfast in a partnership between Queen's University and Almac Discovery. A total of £13m will be invested in two projects, with a further £7m offered by Invest Northern Ireland, which includes part funding from the European Regional Development Fund.
06 October 2006
Queen's appeal for body donations
The Department of Health has today urged more people to consider leaving their bodies to medical science. Many people donate kidneys, livers and other organs by joining the Organ Donor Register, yet the number of people in Northern Ireland leaving their whole bodies for medical research has fallen.